Author:
Albalooshi Y.,Doberentz E.,Madea B.
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference26 articles.
1. Autore C, Quarta G, Spirito P (2007) Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Curr Treat Options Cardiovasc Med 9(6):431–435
2. Maron BJ, Spirito P, Shen WK et al (2007) Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298(4):405–412
3. Begley DA, Mohiddin SA, Tripodi D et al (2003) Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 26(9):1887–1896
4. Bollmann A, Husser D, Cannom DS (2005) Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Am J Cardiovasc Drugs 5(6):371–378
5. Swerdlow CD, Russo AM, Degroot PJ (2007) The dilemma of ICD implant testing. Pacing Clin Electrophysiol 30(5):675–700